Parotitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Parotitis}} | {{Parotitis}} | ||
{{CMG}} | {{CMG}} {{AE}} {{Faizan}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
Revision as of 13:13, 12 August 2015
|
Parotitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parotitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Parotitis medical therapy |
|
Risk calculators and risk factors for Parotitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
- Parotitis[1]
- 1. Causative pathogens
- Staphylococcus aureus
- Streptococcus pyogenes
- Mumps
- Aerobic gram-negative bacilli
- Enterovirus
- Influenza virus
___Antimicrobial Regimen___
- 2. Empiric antimicrobial therapy
- Preferred regimen (MSSA suspected): Nafcillin 2 g IV q4h OR Oxacillin 2 g IV q4h
- Preferred regimen (MRSA suspected): Vancomycin 1 g IV q12h
The treatment of viral parotitis is largely supportive.
References
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.